Pre- implantation and parental diagnosis may be defined as a test done in the human cells to allow the experts to know and understand the genetic composition of the unborn child. The pre-implementation parental genetic diagnosis has been used since the past decades to determine disorders among the humans(Meites, 2013). The test and the results have great advantage in selective pregnancy termination and giving birth to healthy children who are free from most human disorders. Through the process, it is very possible to screen various genetic diseases before birth. For instance, the application of vitro fertilization inpreimplantation genetic diagnosis (PGD)as resulted to treatment of infertility in women and couples with complex genetic mutations. Additionally, the use of PDG assist in the cell transplantation for cases which involves the sex selection and removal of embryos with defects (Meites, 2013). For example, the cells that can lead to deafness among siblings can be removed at embryonic stage.
On the other hand, the preimplantation and parental diagnosis must be carried under the authorization of clinical laboratories and government agencies to ensure accuracy and reliability of the results. Moreover, the human rights and expectations must be a key priority to check by the expertise in the PDG. For example, no court can decide and rule on issues and persuasive arguments that individuals have the right to reproduce rather it is a personal decision for one to reproduce. In summary, the genetic complications of phenotypes cannot be determined through experiments but rather through the preimplantation and parentaldiagnosis that give accurate analysis which is definite. Therefore, matching the embryonic cells should be taken into look as it will help ill sibling by controlling nonfatal disorders and give quality life to the human species (Meites, 2013).
Meites, S. (Ed.). (2013). Standard Methods of Clinical Chemistry: By the American Association of Clinical Chemists. Elsevier.